A new innovative electronic urology stent registry: Reimagined and automated for the digital era

Objective: To evaluate the safety, completeness, and performance of a fully automated electronic ureteric stent registry designed to ensure full traceability and reliable capture of both retrograde and antegrade stents. Patients and Methods: All stent journeys between May 2022 and December 2024 were analysed. The registry is generated prospectively via electronic procedure requests with automated validation, cross-checking, and alert systems. Outcomes included completeness of capture, dwell time distribution, delayed stents, and classification of registry errors. Results: The system captured all stent journeys during the study period. Delayed stents were identified and monitored through automated alerts. Major registry errors present during the first audit cycle were eliminated following targeted staff education and clinical oversight. No stents were lost, including antegrade interventional radiology insertions. Conclusion: A fully automated electronic stent registry can achieve complete traceability, improve safety, and provide a scalable model for ureteric stent surveillance in modern clinical practice. Level of Evidence: Level III (retrospective observational study).